Clinical RoundupFree CIMAvax-EGF well tolerated for NSCLC, initial findings show September 28, 2018Vol.44 No.36
Clinical Roundup Early positive results from phase II DPX-Survivac + Keytruda in DLBCL September 21, 2018Vol.44 No.35
Clinical RoundupFree Study details incidence and timing of immunotherapy-related fatalities September 14, 2018Vol.44 No.34
Clinical RoundupFree CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer September 14, 2018Vol.44 No.34
Clinical RoundupFree IMV Inc. and Merck to evaluate DPX-Survivac + Keytruda September 14, 2018Vol.44 No.34
Clinical RoundupFree Clinical trial shows best outcomes to date for older Hodgkin lymphoma patients September 14, 2018Vol.44 No.34
Clinical RoundupFree Children who develop ALL may have dysregulated immune function at birth September 14, 2018Vol.44 No.34
Clinical RoundupFree Drug for pancreatic cancer targets two genes at a time September 14, 2018Vol.44 No.34
Clinical Roundup SOLAR-1 trial of Novartis meets primary endpoint in HR+/HER2- advanced breast cancer September 07, 2018Vol.44 No.33
